Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
CA 2435067 C · Owner: Chen, Mi · Inventors: Penuliar, Richard; Chen, Mi; Arrhenius, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel compounds (I) their prodrugs, and, the pharmaceutically acceptable salts as well as pharmaceutical compositions containing, such compounds useful in treating certain metabolic diseases and diseases modulated by, the inhibition of the enzyme malonyl-coenzyme A decarboxylase (malonyl-CoA decarboxylase, MCD). In particular, the invention relates to compounds and compositions and the methods for the prophylaxis, management and treatment of cardiovascular diseases, diabetes, acidosis, and obesity through the inhibition of malonyl-coenzyme A decarboxylase.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 22, 2002 and granted November 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.